COM:REZOLUTEBIO
Rezolute, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.rezolutebio.com/ipo date
Jan 14, 2013
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder...Show More